Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

Medically reviewed by Robert Burakoff, MD Fatty liver disease is a health condition in which fat builds up in the liver. This ...

One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague ...

Turmeric is known for its anti-inflammatory properties, but is it bad for your liver? Discover when turmeric supports liver ...

China: A large-scale U.S. analysis has revealed that people living with both type 2 diabetes (T2DM) and chronic kidney ...

Immmunotherapy-based treatments demonstrate effectiveness and safety profiles consistent with clinical trials in real-world setting.

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Discover the critical insights from top liver specialist Dr. Saurabh Sethi on liver health, revealing facts about liver ...

Fingernails reflect internal health. Changes in nail color or texture may signal health problems. Pale nails may indicate ...

Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy received Food and Drug Administration approval to treat a serious form of liver disease, beating rival Eli Lilly & Co. to the US market for the ...